Dilatair
Brand Name: Dilatair
Generic Name: Doxofylline
Active
Registration Number
DR-XY42871
Dosage Form
Tablet
Issuance Date
August 4, 2023
Expiry Date
November 24, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength400 mg
PackagingAmber PVC-PVDC/Alu Blister Pack x 10's (Box of 30 tablets)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Drug for Obstructive Airway Disease (Xanthines)
A
Application
Renewal
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
DoxofyllineActive
Monograph: Doxofylline